• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用基于聚合物的纳米结构靶向易损斑块巨噬细胞。

Targeting of vulnerable plaque macrophages with polymer-based nanostructures.

作者信息

Broz Pavel, Marsch Stephan, Hunziker Patrick

机构信息

Medical Intensive Care Unit, University Hospital Basel, 4031 Basel, Switzerland.

出版信息

Trends Cardiovasc Med. 2007 Aug;17(6):190-6. doi: 10.1016/j.tcm.2007.05.002.

DOI:10.1016/j.tcm.2007.05.002
PMID:17662913
Abstract

Macrophages are key cellular elements of atherosclerotic plaque pathogenesis and are a significant risk factor for plaque rupture. Current diagnostic techniques for the detection of plaque macrophages are often limited by insufficient sensitivity and selectivity and have not reached broad clinical practice until now. Supramolecular nanometer-sized structures such as conjugates, nanoparticles, micelles, or vesicles built from novel polymers promise to be useful in cell-specific delivery and may be of particular value for the detection and treatment of vulnerable plaque macrophages. Key properties of polymer-based nanostructures are high stability, improved biocompatibility, long circulation half-lives, defined biodegradation, targeting moieties, and triggerable controlled release. This review gives an insight into several promising research projects with polymer-based nanostructures for macrophage detection or treatment that might enter cardiologic practice in the near future.

摘要

巨噬细胞是动脉粥样硬化斑块发病机制的关键细胞成分,也是斑块破裂的重要危险因素。目前用于检测斑块巨噬细胞的诊断技术常常受到灵敏度和选择性不足的限制,至今尚未广泛应用于临床实践。由新型聚合物构建的超分子纳米结构,如缀合物、纳米颗粒、胶束或囊泡,有望用于细胞特异性递送,对于易损斑块巨噬细胞的检测和治疗可能具有特殊价值。基于聚合物的纳米结构的关键特性包括高稳定性、改善的生物相容性、较长的循环半衰期、明确的生物降解性、靶向部分以及可触发的控释。本文综述了几个有前景的基于聚合物纳米结构用于巨噬细胞检测或治疗的研究项目,这些项目可能在不久的将来进入心脏病学实践。

相似文献

1
Targeting of vulnerable plaque macrophages with polymer-based nanostructures.用基于聚合物的纳米结构靶向易损斑块巨噬细胞。
Trends Cardiovasc Med. 2007 Aug;17(6):190-6. doi: 10.1016/j.tcm.2007.05.002.
2
Inhibition of macrophage phagocytotic activity by a receptor-targeted polymer vesicle-based drug delivery formulation of pravastatin.普伐他汀基于受体靶向聚合物囊泡的药物递送制剂对巨噬细胞吞噬活性的抑制作用。
J Cardiovasc Pharmacol. 2008 Mar;51(3):246-52. doi: 10.1097/FJC.0b013e3181624aed.
3
Fabrication of nanoparticles within polymeric pores for controlled release of drug.在聚合物孔隙内制备纳米颗粒以实现药物的控释。
Pak J Pharm Sci. 2006 Jan;19(1):73-84.
4
Review: nanoparticles in drug delivery for the treatment of cancer.综述:用于癌症治疗的药物递送中的纳米颗粒
Pak J Pharm Sci. 2006 Jul;19(3):258-68.
5
From vulnerable plaque to vulnerable patient: the search for biomarkers of plaque destabilization.从易损斑块到易损患者:探寻斑块不稳定的生物标志物
Trends Cardiovasc Med. 2007 Jul;17(5):162-71. doi: 10.1016/j.tcm.2007.03.006.
6
Cyclodextrin-based supramolecular architectures: syntheses, structures, and applications for drug and gene delivery.基于环糊精的超分子结构:药物与基因递送的合成、结构及应用
Adv Drug Deliv Rev. 2008 Jun 10;60(9):1000-17. doi: 10.1016/j.addr.2008.02.011. Epub 2008 Mar 4.
7
The dawning era of polymer therapeutics.聚合物疗法的崭新时代。
Nat Rev Drug Discov. 2003 May;2(5):347-60. doi: 10.1038/nrd1088.
8
Biohybrid nanosystems with polymer nanofibers and nanotubes.具有聚合物纳米纤维和纳米管的生物杂交纳米系统。
Appl Microbiol Biotechnol. 2006 Jul;71(4):387-93. doi: 10.1007/s00253-006-0356-z. Epub 2006 Jun 10.
9
Antitubercular inhaled therapy: opportunities, progress and challenges.抗结核吸入疗法:机遇、进展与挑战。
J Antimicrob Chemother. 2005 Apr;55(4):430-5. doi: 10.1093/jac/dki027. Epub 2005 Mar 10.
10
Biodegradable amphiphilic polymer-drug conjugate micelles.可生物降解的两亲性聚合物-药物共轭胶束
Expert Opin Drug Deliv. 2009 Oct;6(10):1079-90. doi: 10.1517/17425240903158917.

引用本文的文献

1
Regulating mitochondrial homeostasis and inhibiting inflammatory responses through Celastrol.通过雷公藤红素调节线粒体稳态并抑制炎症反应。
Ann Transl Med. 2022 Apr;10(7):400. doi: 10.21037/atm-21-7015.
2
Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications.基于纳米颗粒的药物输送:癌症和心血管应用的案例研究。
Cell Mol Life Sci. 2012 Feb;69(3):389-404. doi: 10.1007/s00018-011-0856-6. Epub 2011 Oct 21.
3
Polymer-based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosis.
基于聚合物的治疗方法:用于动脉粥样硬化管理的纳米组装体和纳米颗粒。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011 Jul-Aug;3(4):400-20. doi: 10.1002/wnan.145. Epub 2011 Apr 26.
4
Tyrosine polyethylene glycol (PEG)-micelle magnetic resonance contrast agent for the detection of lipid rich areas in atherosclerotic plaque.用于检测动脉粥样硬化斑块中富含脂质区域的酪氨酸聚乙二醇(PEG)胶束磁共振对比剂。
Magn Reson Med. 2009 Nov;62(5):1195-201. doi: 10.1002/mrm.22103.